Who
Thomas Cusack
Director
Company insider
Files Form 4 as: Director, Heron Therapeutics.
In numbers
- Trades disclosed
- 4
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 8 Nov 2025
- Last trade
- 30 Jan 2026
- Last filed
- 3 Feb 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jan 2026filed 3 Feb 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code A | —53,960 at $0.00 | filing |
| 30 Jan 2026filed 3 Feb 2026 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code A | —53,960 at $0.00 | filing |
| 8 Nov 2025filed 12 Nov 2025 | HRTX Heron Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | $250K227,272 at $1.10 | filing |
| 8 Nov 2025filed 12 Nov 2025 | HRTX Heron TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,879 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.